Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals

被引：0
|
作者：
Jagpreet Chhatwal
Tianhua He
Maria A. Lopez-Olivo
机构：
[1] Harvard Medical School,Institute for Technology Assessment, Massachusetts General Hospital
[2] Tsinghua University School of Medicine,Department of General Internal Medicine
[3] The University of Texas,undefined
[4] MD Anderson Cancer Center,undefined
来源：
PharmacoEconomics | 2016年 / 34卷
关键词：
Sustained Virological Response Rate; Telaprevir; Sofosbuvir; Boceprevir; Consolidate Health Economic Evaluation Reporting Standard;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：551 / 567
页数：16
相关论文
共 50 条
  • [1] Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals
    Chhatwal, Jagpreet
    He, Tianhua
    Lopez-Olivo, Maria A.
    PHARMACOECONOMICS, 2016, 34 (06) : 551 - 567
  • [2] Direct-acting antivirals for hepatitis C treatment: effectiveness versus cost-effectiveness
    Chhatwal, Jagpreet
    FUTURE VIROLOGY, 2015, 10 (08) : 929 - 932
  • [3] Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong
    Lo, Angeline Oi-Shan
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (05) : 1071 - 1078
  • [4] Safety of direct-acting antivirals in the treatment of chronic hepatitis C
    Ridruejo, Ezequiel
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (03) : 307 - 319
  • [5] Measure of adherence to direct-acting antivirals as a predictor of the effectiveness of hepatitis C treatment
    Campos Fernandez de Sevilla, Maria Angeles
    Gallego Ubeda, Marta
    Tovar Pozo, Maria
    Garcia-Cabrera, Emilio
    Monje Garcia, Beatriz
    Tutau Gomez, Federico
    Delgado Tellez de Cepeda, Laura
    Iglesias-Peinado, Irene
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (06) : 1545 - 1554
  • [6] Treatment of hepatitis C in HIV patients in the new era of direct-acting antivirals
    Fernández-Montero J.V.
    Vispo E.
    Barreiro P.
    De Mendoza C.
    Labarga P.
    Soriano V.
    Current Hepatitis Reports, 2013, 12 (4) : 269 - 275
  • [7] Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
    Aggarwal, Rakesh
    Chen, Qiushi
    Goel, Amit
    Seguy, Nicole
    Pendse, Razia
    Ayer, Turgay
    Chhatwal, Jagpreet
    PLOS ONE, 2017, 12 (05):
  • [8] New direct-acting antivirals' combination for the treatment of chronic hepatitis C
    Asselah, Tarik
    Marcellin, Patrick
    LIVER INTERNATIONAL, 2011, 31 : 68 - 77
  • [9] Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis
    Castro, Rodolfo
    Perazzo, Hugo
    Artilles Mello Mendonca de Araujo, Leticia
    Gutierres, Isabella Goncalves
    Grinsztejn, Beatriz
    Veloso, Valdilea G.
    PLOS ONE, 2020, 15 (02):
  • [10] Cost effectiveness of direct acting antivirals in the treatment of hepatitis C in vulnerable populations
    Verma, Dhruv
    Ashkar, Carina
    Saab, Sammy
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (01) : 9 - 12
12345